Skip to main content

UBS Group AG

Position in BCLI — Brainstorm Cell Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in BCLI

as of Jun 30, 2025 · filed Aug 14, 2025
Position Value
$13,864
+$13,547 QoQ
Shares Held
12,380
+4793.3% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in BCLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in BCLI

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2025-06-30 $13,864 12,380
2025-03-31 $317 253
2024-12-31 $7,880 3,472
2024-09-30 $575 2,501
2024-06-30 $2,417 7,110
2024-03-31 $1,400 2,500
2023-12-31 $675 2,500
2023-09-30 $728 3,640
2023-06-30 $5,150 2,500
2023-03-31 $24,750 7,500
2022-12-31 $12,300 7,500
2022-09-30 $33,150 7,500
2022-06-30 $21,514 7,795
2022-03-31 $25,892 7,706
2021-12-31 $57,628 14,407
2021-09-30 $36,326 11,008
2021-06-30 $53,230 14,008
2021-03-31 $62,421 16,298
2020-12-31 $51,297 11,324
2020-09-30 $143,820 8,500
2020-06-30 $189,953 16,945
2020-03-31 $11,600 2,500